Innovassynth Investments

Innovassynth Investments Limited is a public investment holding company, which was established on February 15, 2008, with its business operations centered in India. The company's philosophy is committed to achieving high standards of corporate governance, holding management accountable to all stakeholders through fairness, ethics, and transparency. Its primary activity is investing in its associate, Innovassynth Technologies (India) Limited (ITIL), an internationally recognized manufacturer of specialty chemicals like nucleosides and amides. This associate, ITIL, is a research-driven organization focused on developing and manufacturing specialty chemicals and pharmaceutical intermediates through contract research and custom synthesis. A niche focus for the associate is producing protected nucleosides and modified phosphonamidites, which are key components for therapeutic and diagnostic oligonucleotide applications globally. Since the performance of ITIL is the key factor for its own sustainability, the company maintains an optimistic outlook on its associate's performance.;